Skip to main content
Signal8

Zack Debra

SEC insider (Form 3/4/5 filer). CIK 0001807743. Chief Medical Officer at Spero Therapeutics, Inc. (SPRO). 1 reported Form 4/5 transaction since Sep 2024; latest on Aug 3, 2026. Located in CAMBRIDGE, MA.

Companies Zack Debra has filed insider reports for

  • Spero Therapeutics, Inc. (SPRO): Officer, Chief Medical Officer
Zack Debra profile photo

Zack Debra

CIK: 0001807743

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Spero Therapeutics, Inc. logo
SPRO

Spero Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • Spero Therapeutics, Inc. logo
    SPRO

    Spero Therapeutics, Inc.

    Aug 3, 2026
    Award
    Direct
    162.3K shares-

1-1 of 1